P.O. Box 50030 London, ON N6A 6H8 info@rett.ca (519) 474-6877

Priority Review by Health Canada

Just announced at the 2024 Ascend Rett National Conference, Health Canada has accepted regulatory applications from Acadia Pharmaceuticals for DayBue (Trofinetide), but has also been accepted for a priority review by Health Canada. We were honored to be… Read More

2024 Research Grant Awarded

The Board of Directors has unanimously approved the funding of two research grants totaling $100,000 from the Hope Fund for 2024. Both projects have strong scientific merit and show promise into future Rett research. The Hope Fund was… Read More